Results 171 to 180 of about 402,905 (265)
Risk-Based Survival Outcomes in Early-Stage Endometrial Cancer: Impact of Radiation Therapy. [PDF]
Han KH +5 more
europepmc +1 more source
Interval Progress in Gender Diversity Among Obstetrics and Gynecology Leadership Positions. [PDF]
Sarker M, Gyamfi-Bannerman C, Bruno AM.
europepmc +1 more source
ABSTRACT Healthcare providers worldwide face challenges in maintaining a delicate balance between rising demand and limited resources. Decision‐makers often struggle with planning and implementing new services, leading to costly consequences and hindering efficiency, patient outcomes, and staff well‐being. Current systems lack a comprehensive modelling
Eren Demir
wiley +1 more source
Impact of cervical preservation on vaginal length and female sexual function after hysterectomy for benign conditions: a retrospective cohort study. [PDF]
Doğan O +4 more
europepmc +1 more source
Living at genetic risk: The patient experience of Lynch syndrome
Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents +2 more
wiley +1 more source
A Rare Case of Uterine Artery Pseudoaneurysm After Hysteroscopic Management of Trophoblastic Disease. [PDF]
Tandashvili L +4 more
europepmc +1 more source
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia +4 more
wiley +1 more source
Author Correction: PCM1 orchestrates centrosomal and flagellar protein transport to promote sperm maturation. [PDF]
Huang Z +16 more
europepmc +1 more source
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Manuel Hörner +16 more
wiley +1 more source

